We've all heard about Ozempic — a medication that treats diabetes but is largely used to lose weight. But not everyone does ...

The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the ...

The medication initially helped get his type 2 diabetes into remission, and enjoy active social excursions that he couldn't ...

Prescription drug market expands rapidly due to AI in pharma, rising diseases, and global access to advanced therapies. The prescription drugs market will grow from $1,240.33B in 2024 to $2,151.63B by ...

As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

A growing number of obese adults and children have been prescribed Ozempic or similar medications to lose weight ...

Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...